272 related articles for article (PubMed ID: 8584782)
1. [Mild variant of malignant hyperthermia following succinylcholine and halogenated agent exposure].
Fernández-García V; Bermejo MA; Vázquez C; Pereda MJ; Altarriba JM; Alvarez E
Rev Esp Anestesiol Reanim; 1995 Nov; 42(9):401-2. PubMed ID: 8584782
[No Abstract] [Full Text] [Related]
2. Malignant hyperthermia during desflurane-succinylcholine anesthesia for orthopedic surgery.
Garrido S; Fraga M; Martín MJ; Belda J
Anesthesiology; 1999 Apr; 90(4):1208-9. PubMed ID: 10201695
[No Abstract] [Full Text] [Related]
3. No response to trigger agents in a malignant hyperthermia-susceptible patient.
Claxton BA; Cross MH; Hopkins PM
Br J Anaesth; 2002 Jun; 88(6):870-3. PubMed ID: 12173209
[TBL] [Abstract][Full Text] [Related]
4. [Atypical malignant hyperthermia. A higher incidence than expected].
Herrero E; Casinello F; de Stefano J; Fernández-Guisasola J; Pérez-Gallardo A
Rev Esp Anestesiol Reanim; 1996 Jan; 43(1):42-3. PubMed ID: 8851836
[No Abstract] [Full Text] [Related]
5. Duchenne muscular dystrophy: Which is the best anesthetic agent?
Driessen J; Snoeck M
Paediatr Anaesth; 2008 Oct; 18(10):1007-8. PubMed ID: 18811853
[No Abstract] [Full Text] [Related]
6. Human malignant hyperthermia associated with desflurane anesthesia.
Allen GC; Brubaker CL
Anesth Analg; 1998 Jun; 86(6):1328-31. PubMed ID: 9620529
[No Abstract] [Full Text] [Related]
7. Suxamethonium, masseter spasm and later malignant hyperthermia.
Ramirez JA; Cheetham ED; Laurence AS; Hopkins PM
Anaesthesia; 1998 Nov; 53(11):1111-6. PubMed ID: 10023282
[TBL] [Abstract][Full Text] [Related]
8. Malignant hyperthermia-like syndrome and carnitine palmitoyltransferase II deficiency with heterozygous R503C mutation.
Hogan KJ; Vladutiu GD
Anesth Analg; 2009 Oct; 109(4):1070-2. PubMed ID: 19762733
[TBL] [Abstract][Full Text] [Related]
9. Fatal malignant hyperthermia--delayed onset and atypical course.
Karger B; Teige K
Forensic Sci Int; 2002 Oct; 129(3):187-90. PubMed ID: 12372688
[TBL] [Abstract][Full Text] [Related]
10. Malignant hyperthermia induced by general anesthesia for bone marrow harvesting.
Hosoya N; Miyagawa K; Mimura T; Hoshide S; Akazawa H; Kanda Y; Takahashi N; Hirai H; Maekawa K; Yazaki Y
Bone Marrow Transplant; 1997 Mar; 19(5):509-11. PubMed ID: 9052921
[TBL] [Abstract][Full Text] [Related]
11. Estimate of the relative risk of succinylcholine for triggering malignant hyperthermia.
Dexter F; Epstein RH; Wachtel RE; Rosenberg H
Anesth Analg; 2013 Jan; 116(1):118-22. PubMed ID: 23223104
[TBL] [Abstract][Full Text] [Related]
12. The risk of malignant hyperthermia in children undergoing muscle biopsy for suspected neuromuscular disorder.
Flick RP; Gleich SJ; Herr MM; Wedel DJ
Paediatr Anaesth; 2007 Jan; 17(1):22-7. PubMed ID: 17184427
[TBL] [Abstract][Full Text] [Related]
13. [Anesthesia in hereditary peripheral muscular disease].
Islander G; Jungner M
Lakartidningen; 2005 Feb 21-27; 102(8):566-71. PubMed ID: 15786909
[No Abstract] [Full Text] [Related]
14. [Malignant hyperthermia].
Glahn KP
Ugeskr Laeger; 2003 Apr; 165(17):1763-8. PubMed ID: 12768904
[TBL] [Abstract][Full Text] [Related]
15. [ENT anesthesia: the German Society of Anesthesia and Intensive Care Medicine on the use of succinylcholine].
HNO; 1995 Nov; 43(11):640-1. PubMed ID: 8530309
[No Abstract] [Full Text] [Related]
16. Unexpected MH deaths without exposure to inhalation anesthetics in pediatric patients.
Brandom BW; Muldoon SM
Paediatr Anaesth; 2013 Sep; 23(9):851-4. PubMed ID: 23848295
[TBL] [Abstract][Full Text] [Related]
17. Malignant hyperthermia and muscular dystrophies.
Gurnaney H; Brown A; Litman RS
Anesth Analg; 2009 Oct; 109(4):1043-8. PubMed ID: 19762730
[TBL] [Abstract][Full Text] [Related]
18. Malignant hyperthermia: a case report in Thai Anesthesia Incidents Study (THAI Study).
Pulnitiporn A; Charuluxananan S; Inphum P; Kitsampanwong W
J Med Assoc Thai; 2005 Nov; 88 Suppl 7():S149-52. PubMed ID: 16862689
[TBL] [Abstract][Full Text] [Related]
19. Volatile anesthetics and succinylcholine in cardiac ryanodine receptor defects.
Swan H; Laitinen PJ; Toivonen L
Anesth Analg; 2004 Aug; 99(2):435-7, table of contents. PubMed ID: 15271719
[TBL] [Abstract][Full Text] [Related]
20. Neuromuscular and mitochondrial disorders: what is relevant to the anaesthesiologist?
Driessen JJ
Curr Opin Anaesthesiol; 2008 Jun; 21(3):350-5. PubMed ID: 18458553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
